MARKET

HBIO

HBIO

Harvard Biosci
NASDAQ
6.66
-0.02
-0.22%
After Hours: 6.66 0 0.00% 19:34 08/14 EDT
OPEN
6.61
PREV CLOSE
6.67
HIGH
6.70
LOW
6.51
VOLUME
15.42K
TURNOVER
--
52 WEEK HIGH
9.40
52 WEEK LOW
3.755
MARKET CAP
30.30M
P/E (TTM)
-3.0316
1D
5D
1M
3M
1Y
5Y
1D
Harvard Bioscience Price Target Raised to $7.50/Share From $6.00 by Benchmark
Dow Jones · 4d ago
Harvard Bioscience Is Maintained at Speculative Buy by Benchmark
Dow Jones · 4d ago
Benchmark Maintains Speculative Buy on Harvard Bioscience, Raises Price Target to $7.5
Benzinga · 4d ago
Harvard Bioscience's Q2 Revenue Rises 11%; Raises FY26 Growth Outlook
NASDAQ · 5d ago
Harvard Bioscience Advances Transformation with Project Viking Launch
TipRanks · 5d ago
Harvard Bioscience beats top-line and bottom-line estimates; gives Q3 and raises FY2026 outlook
Seeking Alpha · 5d ago
*Harvard Bioscience Sees 3Q Rev $21M-$22.6M >HBIO
Dow Jones · 5d ago
*Harvard Bioscience Sees 2026 Revenue Growth of 3% to 5% >HBIO
Dow Jones · 5d ago
More
About HBIO
Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.

Webull offers Harvard Bioscience Inc stock information, including NASDAQ: HBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HBIO stock methods without spending real money on the virtual paper trading platform.